Exact Mass: 265.1681942

Exact Mass Matches: 265.1681942

Found 51 metabolites which its exact mass value is equals to given mass value 265.1681942, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Oxprenolol

1-[2-(prop-2-en-1-yloxy)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol

C15H23NO3 (265.1677848)


Oxprenolol is only found in individuals that have used or taken this drug. It is a non-selective beta blocker with some intrinsic sympathomimetic activity. It is used for the treatment of angina pectoris, abnormal heart rhythms, anxiety, and high blood pressure. Oxprenolol is a lipophilic beta blocker which passes the blood-brain barrier more easily than water-soluble beta blockers. As such, it is associated with a higher incidence of CNS-related side effects than beta blockers with more hydrophilic molecules such as atenolol, sotalol, and nadolol (Wikipedia). Like other beta-adrenergic antagonists, oxprenolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, oxprenolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, oxprenolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Oxprenolol, therefore, inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

4-Hydroxy-alprenolol

4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}-3-(prop-2-en-1-yl)phenol

C15H23NO3 (265.1677848)


4-Hydroxy-alprenolol is a metabolite of alprenolol. Alprenolol, or alfeprol, alpheprol, and alprenololum (Gubernal, Regletin, Yobir, Apllobal, Aptine, Aptol Duriles), is a non-selective beta blocker as well as 5-HT1A receptor antagonist, used in the treatment of angina pectoris. It is no longer marketed by AstraZeneca, but may still be available from other pharmaceutical companies or generically. (Wikipedia)

   
   
   
   
   

(9aS)-6t-furan-3-yl-3,9c-dimethyl-(9ar)-octahydro-quinolizine-3c,4xi-diol|Deoxynupharidin-6,7ss-diol|deoxynupharidine-6xi,7-diol

(9aS)-6t-furan-3-yl-3,9c-dimethyl-(9ar)-octahydro-quinolizine-3c,4xi-diol|Deoxynupharidin-6,7ss-diol|deoxynupharidine-6xi,7-diol

C15H23NO3 (265.1677848)


   
   

8beta-amino-10beta-hydroxyeremophyl-7(11)-en-12,8alpha-olide|rel-(4aR,5S,8aS,9aS)-9a-amino-4a,5,6,7,8,8a,9,9a-octahydro-8a-hydroxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one

8beta-amino-10beta-hydroxyeremophyl-7(11)-en-12,8alpha-olide|rel-(4aR,5S,8aS,9aS)-9a-amino-4a,5,6,7,8,8a,9,9a-octahydro-8a-hydroxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one

C15H23NO3 (265.1677848)


   

oxprenolol

oxprenolol

C15H23NO3 (265.1677848)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3128 CONFIDENCE standard compound; INTERNAL_ID 2209

   

Coretal

1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol

C15H23NO3 (265.1677848)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine

1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine

C14H27NSi2 (265.1681942)


   

2-methylpropyl 1-(furan-2-ylmethyl)piperidine-4-carboxylate

2-methylpropyl 1-(furan-2-ylmethyl)piperidine-4-carboxylate

C15H23NO3 (265.1677848)


   

3-AMINO-3-(4-HEXYLOXY-PHENYL)-PROPIONIC ACID

3-AMINO-3-(4-HEXYLOXY-PHENYL)-PROPIONIC ACID

C15H23NO3 (265.1677848)


   

5-TERT-BUTYL-2-PIPERIDIN-1-YLMETHYL-FURAN-3-CARBOXYLIC ACID

5-TERT-BUTYL-2-PIPERIDIN-1-YLMETHYL-FURAN-3-CARBOXYLIC ACID

C15H23NO3 (265.1677848)


   

5-TERT-BUTYL-2-METHYL-4-PYRROLIDIN-1-YLMETHYL-FURAN-3-CARBOXYLIC ACID

5-TERT-BUTYL-2-METHYL-4-PYRROLIDIN-1-YLMETHYL-FURAN-3-CARBOXYLIC ACID

C15H23NO3 (265.1677848)


   

1-BENZYL-1-AZA-12-CROWN-4

1-BENZYL-1-AZA-12-CROWN-4

C15H23NO3 (265.1677848)


   

Etilefrine pivalate

[3-[2-(ethylamino)-1-hydroxyethyl]phenyl] 2,2-dimethylpropanoate

C15H23NO3 (265.1677848)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent

   

4-[(1-ADAMANTYLCARBONYL)AMINO]BUTANOIC ACID

4-[(1-ADAMANTYLCARBONYL)AMINO]BUTANOIC ACID

C15H23NO3 (265.1677848)


   

2-butoxyethyl 4-(dimethylamino)benzoate

2-butoxyethyl 4-(dimethylamino)benzoate

C15H23NO3 (265.1677848)


   

2-(dimethylamino)ethanol,prop-2-enoic acid,styrene

2-(dimethylamino)ethanol,prop-2-enoic acid,styrene

C15H23NO3 (265.1677848)


   

3-Azaspiro[5.5]undec-7-ene-3-carboxylic acid, 9-oxo-, 1,1-diMethylethyl ester

3-Azaspiro[5.5]undec-7-ene-3-carboxylic acid, 9-oxo-, 1,1-diMethylethyl ester

C15H23NO3 (265.1677848)


   

P-NITROPHENYL NONYL ETHER

P-NITROPHENYL NONYL ETHER

C15H23NO3 (265.1677848)


   

TERT-BUTYL (4-HYDROXY-2-PHENYLBUTAN-2-YL)CARBAMATE

TERT-BUTYL (4-HYDROXY-2-PHENYLBUTAN-2-YL)CARBAMATE

C15H23NO3 (265.1677848)


   

2-(6,7-diethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)ethanol

2-(6,7-diethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)ethanol

C15H23NO3 (265.1677848)


   

5-isobutyl-2-methyl-4-pyrrolidin-1-ylmethyl-furan-3-carboxylic acid

5-isobutyl-2-methyl-4-pyrrolidin-1-ylmethyl-furan-3-carboxylic acid

C15H23NO3 (265.1677848)


   

N-[(2,3,4-trimethoxyphenyl)methyl]cyclopentanamine

N-[(2,3,4-trimethoxyphenyl)methyl]cyclopentanamine

C15H23NO3 (265.1677848)


   
   

N-methyl-1-(3,4,5-trimethoxyphenyl)pent-4-en-2-amine

N-methyl-1-(3,4,5-trimethoxyphenyl)pent-4-en-2-amine

C15H23NO3 (265.1677848)


   

4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]-3-prop-2-enylphenol

4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]-3-prop-2-enylphenol

C15H23NO3 (265.1677848)


   

Parethoxycaine

Parethoxycaine

C15H23NO3 (265.1677848)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

(3R,4R,5R)-5-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4-diol

(3R,4R,5R)-5-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4-diol

C15H23NO3 (265.1677848)


   

(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol

(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol

C15H23NO3 (265.1677848)


   
   

5-{5-hydroxy-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methylpent-2-enimidic acid

5-{5-hydroxy-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methylpent-2-enimidic acid

C15H23NO3 (265.1677848)


   

(7as)-1-hydroxy-2-octanoyl-5,6,7,7a-tetrahydropyrrolizin-3-one

(7as)-1-hydroxy-2-octanoyl-5,6,7,7a-tetrahydropyrrolizin-3-one

C15H23NO3 (265.1677848)


   

(2e)-5-[(1s,3s,6r,9s)-6-(hydroxymethyl)-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]-2-methylpent-2-enimidic acid

(2e)-5-[(1s,3s,6r,9s)-6-(hydroxymethyl)-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]-2-methylpent-2-enimidic acid

C15H23NO3 (265.1677848)


   

6-(dimethylamino)-1-(4-hydroxy-3-methoxyphenyl)hexan-1-one

6-(dimethylamino)-1-(4-hydroxy-3-methoxyphenyl)hexan-1-one

C15H23NO3 (265.1677848)


   

(1s,2s,3s,6s,8r)-1,4,4-trimethyl-11-methylidene-9-azatricyclo[6.3.1.0²,⁶]dodec-9-ene-3,8,10-triol

(1s,2s,3s,6s,8r)-1,4,4-trimethyl-11-methylidene-9-azatricyclo[6.3.1.0²,⁶]dodec-9-ene-3,8,10-triol

C15H23NO3 (265.1677848)


   

6-(furan-3-yl)-3,9-dimethyl-octahydroquinolizine-3,4-diol

6-(furan-3-yl)-3,9-dimethyl-octahydroquinolizine-3,4-diol

C15H23NO3 (265.1677848)


   

(2s,6z)-6-(aminomethylidene)-5-[(2r)-butan-2-yl]-2-ethyl-4-methoxy-2-methylcyclohex-4-ene-1,3-dione

(2s,6z)-6-(aminomethylidene)-5-[(2r)-butan-2-yl]-2-ethyl-4-methoxy-2-methylcyclohex-4-ene-1,3-dione

C15H23NO3 (265.1677848)


   

(2e)-5-[(6s)-5-hydroxy-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methylpent-2-enimidic acid

(2e)-5-[(6s)-5-hydroxy-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methylpent-2-enimidic acid

C15H23NO3 (265.1677848)


   

(2e)-3-[(1r,4s,7s,9as)-1,7-dimethyl-octahydro-1h-quinolizin-4-yl]-4-oxobut-2-enoic acid

(2e)-3-[(1r,4s,7s,9as)-1,7-dimethyl-octahydro-1h-quinolizin-4-yl]-4-oxobut-2-enoic acid

C15H23NO3 (265.1677848)


   

(4ar,5s,8as,9as)-9a-amino-8a-hydroxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one

(4ar,5s,8as,9as)-9a-amino-8a-hydroxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one

C15H23NO3 (265.1677848)


   

(2s)-6-(aminomethylidene)-5-[(2s)-butan-2-yl]-2-ethyl-4-methoxy-2-methylcyclohex-4-ene-1,3-dione

(2s)-6-(aminomethylidene)-5-[(2s)-butan-2-yl]-2-ethyl-4-methoxy-2-methylcyclohex-4-ene-1,3-dione

C15H23NO3 (265.1677848)


   

3-(1,7-dimethyl-octahydro-1h-quinolizin-4-yl)-4-oxobut-2-enoic acid

3-(1,7-dimethyl-octahydro-1h-quinolizin-4-yl)-4-oxobut-2-enoic acid

C15H23NO3 (265.1677848)


   

9a-amino-8a-hydroxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one

9a-amino-8a-hydroxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one

C15H23NO3 (265.1677848)


   

6-(dimethylamino)-1-(3-hydroxy-4-methoxyphenyl)hexan-1-one

6-(dimethylamino)-1-(3-hydroxy-4-methoxyphenyl)hexan-1-one

C15H23NO3 (265.1677848)


   

6-(aminomethylidene)-2-ethyl-4-methoxy-2-methyl-5-(sec-butyl)cyclohex-4-ene-1,3-dione

6-(aminomethylidene)-2-ethyl-4-methoxy-2-methyl-5-(sec-butyl)cyclohex-4-ene-1,3-dione

C15H23NO3 (265.1677848)


   

(3r,4r,6s,9r,9as)-6-(furan-3-yl)-3,9-dimethyl-octahydroquinolizine-3,4-diol

(3r,4r,6s,9r,9as)-6-(furan-3-yl)-3,9-dimethyl-octahydroquinolizine-3,4-diol

C15H23NO3 (265.1677848)


   

5-[6-(hydroxymethyl)-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]-2-methylpent-2-enimidic acid

5-[6-(hydroxymethyl)-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]-2-methylpent-2-enimidic acid

C15H23NO3 (265.1677848)